Correlation Between Genovis AB and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovis AB and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovis AB and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovis AB and CellaVision AB, you can compare the effects of market volatilities on Genovis AB and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and CellaVision.

Diversification Opportunities for Genovis AB and CellaVision

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genovis and CellaVision is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Genovis AB i.e., Genovis AB and CellaVision go up and down completely randomly.

Pair Corralation between Genovis AB and CellaVision

Assuming the 90 days trading horizon Genovis AB is expected to generate 0.65 times more return on investment than CellaVision. However, Genovis AB is 1.54 times less risky than CellaVision. It trades about 0.1 of its potential returns per unit of risk. CellaVision AB is currently generating about 0.04 per unit of risk. If you would invest  2,365  in Genovis AB on April 24, 2025 and sell it today you would earn a total of  295.00  from holding Genovis AB or generate 12.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.36%
ValuesDaily Returns

Genovis AB  vs.  CellaVision AB

 Performance 
       Timeline  
Genovis AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Genovis AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
CellaVision AB 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CellaVision AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CellaVision may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Genovis AB and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovis AB and CellaVision

The main advantage of trading using opposite Genovis AB and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Genovis AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes